Intemed: International Journal of Research in Integrated Medical Sciences (IJ-RIMS) Open Access | Peer-Reviewed | Integrated Medical Sciences
International Journal
  • ISSN: 3139-0935(Online)
  • Email: shriramragad1992@gmail.com
  • Contact: +91 7387468519
  • Publisher: Shri Dhanvantari International Publication
Open Access, Peer-Reviewed Journal for Research in Integrated Medical Sciences.
Raheri Bk, Sindkhed Raja, Buldhana | Maharashtra, India

Article Details

  1. Home
  2. Articles
Back to articles

Ayurvedic Management of Vidagdhajirna Janya Raktadushti with Virechana Karma Using Trivrut Avaleha: A Case Report

Abstract

Background: Food that is hot, pungent, heavy or eaten at the wrong time, especially in a hot climate, can leave Agni unable to digest it properly. Ayurveda calls this Vidagdhajirna, a Pitta-dominant indigestion, and describes how it can go on to vitiate Rakta, whose root seat is the liver (Yakrit). This report describes a young man with raised liver enzymes and bilirubin who was assessed and treated on these principles. Case presentation: A 28-year-old man who had lived in Dubai presented with six months of chest burning, heaviness and bloating in the left abdomen, and low back pain, plus one month of unsatisfactory bowel habit, hair fall and testicular pain. He had had jaundice a year earlier and had not completed treatment. Total bilirubin was 1.80 mg/dl, direct bilirubin 0.76 mg/dl, SGOT 60.5 U/L and SGPT 108.3 U/L. Earlier imaging had shown a small liver hemangioma and renal calculi. He received 15 days of Pachana, Anuloma and Raktaprasadana medicines, Snehapana with Mahatikta Ghrita for five days, Sarvanga Snehana and Swedana, and Virechana with Trivrut Avaleha (22 Vegas), followed by Samsarjana Krama and Rasayana. Outcome: About six weeks after the first report, SGOT was 35.0 U/L, SGPT 33.7 U/L and total bilirubin 0.84 mg/dl, all within the reference range, and his symptoms had improved. Ultrasound still showed mild fatty change in the liver, and a single tiny calculus remained in the left kidney. Conclusion: In this one patient, a Panchakarma-based plan built around Virechana was followed by normal liver enzymes and bilirubin and by symptomatic relief. Because several treatments were given together, the report suggests a direction for further study and does not show that Trivrut Avaleha alone was responsible.

Keywords
VidagdhajirnaRaktadushtiVirechanaTrivrut AvalehaMahatikta Ghritaraised liver enzymesPanchakarmacase report
References
1. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. 2. Agnivesha. Charaka Samhita, Chikitsa Sthana, Chapter 15: Grahani Chikitsa [Internet]. Charak Samhita Research, Training and Skill Development Centre. Available from: https://www.carakasamhitaonline.com/index.php/Grahani_Chikitsa 3. List of references of the word Virechana in Charaka Samhita (including Sutra Sthana, Chapter 25, Verse 40) [Internet]. Charak Samhita Research, Training and Skill Development Centre. Available from: https://www.carakasamhitaonline.com/images/6/60/List_of_references_of_word_virechana_in_charaka-converted.pdf 4. Chaganti S, Prasad BS. Analysis of Virechana karma with Danti avaleha: a retrospective study. J Ayurveda Integr Med. 2015;6(4):300-4. 5. Huddar VG, Mangane MP, Mumbaraddi SS. Clinical profile of a case of alcoholic liver disease – an Ayurvedic management. Indian J Health Sci Biomed Res KLEU. 2015;8(2):142-6. doi:10.4103/2349-5006.174254 6. Ratha KK, Meher SK. Ayurvedic management of acute viral hepatitis: a case report. Indian J Case Rep. 2018;4(6):511-4. doi:10.32677/IJCR.2018.v04.i06.035 7. Mulay MS. Short term escalating administration of large amount of sneha does not increase blood lipids. J Ayurveda Integr Med. 2020;12(3):535-9. doi:10.1016/j.jaim.2020.05.004 8. Chaturvedi A, Rao PN, Kumar AM, Ravishankar B, Rao N, Ravi M. Effect and mechanism of Virechana karma (therapeutic purgation) over fructose-induced metabolic syndrome: an experimental study. J Evid Based Complementary Altern Med. 2016;21(3):194-201. doi:10.1177/2156587215596283 9. Reading NG, Forbes A, Nunnerley HB, Williams R. Hepatic haemangioma: a critical review of diagnosis and management. Q J Med. 1988;67(2):431-45. 10. Duxbury MS, Garden OJ. Giant haemangioma of the liver: observation or resection? Dig Surg. 2010;27(1):7-11. doi:10.1159/000268108